18FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study

18FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study

Abstract Background Pathologic response to neoadjuvant chemotherapy (neoCTX) is a prognostic factor in many cancer types, and early prediction would help to modify treatment. In patients with gastric and esophagogastric junction (AEG) cancer, the accuracy of FDG PET-CT to predict early pathologic re...

Full description

Bibliographic Details
Main Authors: Paul M. Schneider, Dilmurodjon Eshmuminov, Tamara Rordorf, Diana Vetter, Patrick Veit-Haibach, Achim Weber, Peter Bauerfeind, Panagiotis Samaras, Kuno Lehmann
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Cancer
Subjects:
Histopathologic regression
PET-CT
Gastric cancer
AEG
Online Access:http://link.springer.com/article/10.1186/s12885-018-4477-4

Internet

http://link.springer.com/article/10.1186/s12885-018-4477-4

Similar Items